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Abstract Carissa L. is a genus of the family Apocynaceae, with about 36 species as evergreen shrubs or small trees native
to tropical and subtropical regions of Africa, Asia and Oceania. Most of Carissa plants have been employed and utilized in
traditional medicine for various ailments, such as headache, chest complains, rheumatism, oedema, gonorrhoea, syphilis,
rabies. So far, only nine Carissa species have been phytochemically studied, which led to the identification of 123
compounds including terpenes, flavonoids, lignans, sterols, simple phenolic compounds, fatty acids and esters, and so on.
Pharmacological studies on Carissa species have also indicated various bioactive potentials. This review covers the peer-
reviewed articles between 1954 and 2016, retrieved from Pubmed, ScienceDirect, SciFinder, Wikipedia and Baidu, using
‘‘Carissa’’ as search term (‘‘all fields’’) and with no specific time frame set for search. Fifteen important medicinal or
ornamental Carissa species were selected and summarized on their botanical characteristics, geographical distribution,
traditional uses, phytochemistry, and pharmacological activities.
Keywords Carissa  Apocynaceae  Ethnomedicine  Phytochemistry  Triterpenes  Nortrachelogenin 
Pharmacology
Abbreviations
IC50 Minimum inhibition concentration for inhibiting
50% of the pathogen
CC50 Cytotoxic concentration of the extracts to cause
death to 50% of host’s viable cells
EC50 Half maximal effective concentration
MIC Minimum inhibitory concentration





Carissa L., a genus of the family Apocynaceae with about
250 genera, consists of 36 species as evergreen shrubs or
small trees native to tropical and subtropical regions of
Africa, Asia and Oceania [1, 2]. Among which, four
species, including two introduced plants, C. carandas L.
and C. macrocarpa (Eckl.) A. DC., are distributed in
China [3]. Carissa species possess handsome, glossy
foliage and fragrant, starry-white, jasmine-like flowers.
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The fruits are ornamental and edible, scarlet to crimson in
color, oval in shape and are produced after flowering [2].
Numerous Carissa plants have been employed and uti-
lized in traditional medicine for various ailments, such as
headache, chest complains, rheumatism, oedema, gonor-
rhoea, syphilis, rabies. They have been also used as a
remedy for fever, sickle cell anaemia, cough, ulcer,
toothache, and worm infestation [1]. So far, only nine
Carissa species have been phytochemically studied. Ter-
penes [4–31], flavonoids [5, 6, 19, 32, 33], lignans
[5, 9, 19, 26, 34–36], sterols [5, 6, 11, 15, 17, 31, 37, 38],
simple phenolic compounds [5, 6, 9, 13, 14, 32, 36, 39],
esters [6, 17, 21], fatty acids [17, 40] and other com-
pounds [5–7, 9, 17, 20, 21, 32, 34] were identified across
different species. Pharmacological studies on Carissa
species have indicated significant antiplasmodial [5, 41],
diuretic [42], anticonvulsant [43], antibacterial
[9, 13, 19, 44, 45], anti-oxidant and anti-tumor
[14, 21, 24, 46–49], antiviral [50–52], antiemetic [53],
anti-hyperlipidemic [54], analgesic, anti-inflammatory,
antipyretic activities [55–57], vasorelaxant [58], cardio-
protective [59], hepatoprotective [38, 60–62], antidiabetic
[63] and antihelminthiasis activities [64, 65].
The present article puts forward 15 important medici-
nal or ornamental Carissa species and reports on their
botanical characteristics, geographical distribution, tradi-
tional uses, isolated chemical constituents, structural
illustrations and their investigated pharmacological
activities.
2 Species’ Description, Distribution and Traditional
Uses
Fifteen species used mostly as important folk medicine,
ornamental plants, or wild food resources were selected,
and their local names, botanical description, distribution
and traditional uses were summarized in Table 1.
3 Chemical Constituents
From the genus Carissa, a total of 123 compounds have
been isolated from nine different species, e.g., C. bispi-
nosa, C. carandas, C. congesta, C. edulis, C. grandiflora,
C. lanceolata, C. macrocarpa, C. opaca, and C. spinarum.
The compounds comprise triterpenes (1–22), cardiac gly-
cosides (23–24), sesquiterpenes (25–40), monoterpenes
(41–59), flavonoids (60–66), lignans (67–80), sterols (81–
89), simple phenolic compounds (90–105), fatty acids and
esters (106–114), and other kinds of compounds (115–
123), as shown in Table 2.
3.1 Triterpenes
Twenty-two compounds referring to lupane (1–5, 22),
ursane (6–14), oleanane (15–18 and 20), D:C-friedoleane
triterpene (19) and isohopane (21) type triterpene (Fig. 1),
have been isolated mostly from the roots of C. carandas
[14, 15, 25, 27, 31], C. congesta [17], C. lanceolata [29],
C. opaca [6, 26], and C. spinarum [28, 34]. It showed that
pentacyclic oleanane triterpenes, oleanolic acid (15), b-
amyrin (16), methyl oleanolate (17) and ursane triterpene,
ursolic acid (6), had been isolated mostly from the roots of
C. carandas [14, 15] and the aerial parts of C. macrocarpa
[18]. Isolation of ursolic acid (6) had also been achieved
from the leaves of C. spinarum [19] and C. bispinosa [20].
Other triterpenoids, lupeol b-hydroxyoctadecanoate (4) and
3b,27-dihydroxylup-12-ene (5) had also been isolated and
characterized by Parveen S. et al. from the aerial parts of C.
opaca [26].
Galipali S. et al. investigated the anti-inflammatory
potential of root methanol extracts of C. carandas using
bioassay guided fractionation of extract based on inhibitory
potential towards proinflammatory mediators [TNF-a, IL-
1b and nitric oxide (NO)]. They found out that lupeol (1)
and oleanolic acid (15) exhibited potential anti-inflamma-
tory activities [56].
Carandinol (21) was isolated from the leaves of C.
carandas, along with three known triterpenoid acids,
ursolic acid (6), oleanolic acid (15), and betulinic acid (22),
and its structure as 3b,21a-dihydroxyisohopane was
deduced by exhaustive spectroscopic analyses [24]. In the
same investigation, carandinol (21) was evaluated for
cytotoxicity, immunomodulatory, antiglycation, anti-oxi-
dant and enzyme inhibition activity. It exhibited significant
in vitro cytotoxicity to every cell line tested (HeLa, PC-3
and 3T3) and was relatively more toxic to human cervical
cancer (HeLa) cell line. Their study was the first to report
the isolation of a cytotoxic isohopane triterpene, carandinol
(21), from the genus Carissa. Considering the highest
number of triterpenes isolated and their trends of distri-
bution across the species, there is a higher probability that
they are the most predominant constituents of Carissa.
3.2 Cardiac Glycosides
Cardiac glycosides (Fig. 2, compounds 23 and 24) are
compounds that occur naturally in certain plants species.
They possess qualities that have effects on the heart,
stomach, intestines, and nervous system. Just as the name
cardiac suggests, these compounds are the active ingredient
in many different heart medicines in clinical use and they
are the major class of medications used to treat heart
failure. The cardiotonic activity of C. edulis and its ability
J. S. Kaunda, Y.-J. Zhang
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Table 1 Local names, botanical description, distribution and uses of Carissa species
Scientific names Local names Distribution Uses
C. bispinosa Num-num (English), Noemnoem
(Afrikaans)
Southwestern parts of Western Cape
along coastal areas, Eastern Cape,
KwaZulu-Natal, Gauteng, Northern




Ornamental, berries to make jams and
jellies, roots treat toothache [2]
C. boiviniana Madagascar [66] Unknown







(Marathi), Karamcha (Bengali), Ci-
Huang-Guo (Chinese)
Himalayas, Siwalik Hills, Western
Ghats, Nepal, Afghanistan, India,
Myanmar, Sri Lanka, Indonesia,
China [3, 60], Himalayas, Siwalik
Hills, Western Ghats, Nepal,
Afghanistan, India, Myanmar, Sri
Lanka, Indonesia, China [3, 60]
Antihyperglycemic, hepato-protective
[38, 60–62], colic, rheumatoid
arthritis, piles, indigestion,
splenomegaly, anorexia, cardiac
diseases, oedema, amenorrhoea, anti-
emetic, cardiotonic, anti-bacterial
[44, 45], anti-inflammatory, analgesic
and anti-pyretic [55, 56],
helminthiasis [64, 65], constipation
and diarrhea [67], purgative, snake
bite antidote and remittent fever
[68, 69]
C. congesta Karamcha, Karamya, Karancha
(Bengali), Karaunda (English)
India, Myanmar, Sri Lanka, Philippines
[70]
Fly repellant, sweet ripe fruit for
puddings and jellies. Syrup is drunk.
Leaves, tussar silk-worm fodder.
Wood for fuel, fruits for tanning and
dyeing. Unripe fruits as astringent.
Ripe fruit for biliousness. Leaf
decoction for fever, diarrhea, oral
inflammation and earache. Root
decoction employed as bitter
stomachic and itches. Ornamental
[70]
C. edulis Simple spined Num-Num Botswana, Namibia, Uganda,
Cameroon, Eritrea, Ethiopia, Ghana,
Guinea, Kenya, Nigeria, Saudi
Arabia, Senegal, South Africa,
Sudan, Tanzania, Thailand, Vietnam,
Cambodia, Myanmar, Japan, Yemen
Asia, Indo-China [5]
Antiplasmodial [4, 41], diuretic
activities [42], anticonvulsant [43],
antiherpetic [50], antiviral [51, 52],
antidiabetic [63]
C. grandiflora Natal Plum, common Carissa Southern Africa (Kwa-Zulu/Natal) [71] A screen or hedge [71]
C.
haematocarpa
South Africa-Western Cape to Grahams
Town Eastern Cape, Southern regions
of Namibia, arid Karoo, semi-Karoo
regions [72]
Attracts bees, butterflies, other insects
and birds. For boundary and hedge
[72]
C. lanceolata Conkerberry (English) Western and Northern Australia,
Queensland [1]
Toothache, respiratory infection, colds,
flu, and cleaning of sores [1]
C. macrocarpa Amatungulu (Zulu), Noem-Noem
(Afrikaans), Dahua-Jiahuci (Chinese)
Saudi Arabia, South Africa, Uganda,
China [3, 18]
Antibacterial, fruit, edible, made into
pies, jams, jellies, and sauces.
Ornamental and fencing [18]
C. opaca Northern hilly areas of Pakistan,
Abbottabad, Murree, Margalla Hills,
Kashmir, India, Myanmar, Sri Lanka
[73]
Fencing, edible ripe berries. Fruits and
leaves for jaundice, hepatitis, asthma
and fever; root powder treat wounds
and injuries [73]
C. ovata Currant Bush, Lime, Kunkerberry,
native scrub, Blackberry, Ulorin,
Karey (Australia and Queensland)
Western Australia, south-wards to
northeastern New South Wales.
Grows in 0–900 m altitude, open or
monsoon forest [74, 75]
Ripe fruit edible [74], unripe fruit is
poisonous [75]




Scientific names Local names Distribution Uses
C. spinarum Indian names: vaka, kalivi, kalli
(Andhra Pradesh), karamacha
(Bengal), karmarda (Gujarat),
karekayi, garji, kavali (Karnataka),
karavada, karanda, karwant
(Maharashtra), karondhu, garna,




Tropical Africa, Southern Asia, dry,
sandy, rocky soils of India, Ceylon,
Myanmar, Thailand, China
[3, 66, 76]
Purgative, rheumatism [57], antidote to
snakebites [68, 69], cardiotonic,
anticonvulsant, hepatoprotective,
antiarthritic, antibacterial, lowering
blood pressure [77], cleaning worm
infested wounds [78] and chronic
joint pains management [79]
C. tetramera Sand num-num Kenya, Mozambique, Tanzania,
Swaziland, South Africa, Zimbabwe
[66]
Unknown
C. yunnanensis Yunnan-Jiahuci (Chinese) China, Sri Lanka [80] Unknown
Table 2 Chemical constituents’ classification and trends of distribution in Carissa plants
Nos. Compounds Plant sources Parts References
1 Lupeol C. carandas Root [14, 15, 31]
C. carandas Fruit [16]
C. opaca Root [6]
C. congesta Root [17]
2 16b-Hydroxybetulinic acid C. carandas Root [31]
3 Lupa-12,20(29)-dien-3b,28-diol C. carandas Root [22]
4 Lupeol b-hydroxyoctadecanoate C. opaca Aerial [26]
5 3b,27-Dihydroxylup-12-ene C. opaca Aerial [26]
6 Ursolic acid C. carandas Root [14, 15]
C. macrocarpa Leaf [18]
C. spinarum Leaf [19]
C. bispinosa Leaf [20]
7 Urs-12-ene-3b,22b-diol C. carandas Root [22]
8 Me ursolate C. carandas Root [15]
9 a-Amyrin C. carandas Root [31]
10 Carissic acid C. carandas Leaf [25]
11 Carissic acid methyl ester C. carandas Leaf [25]
12 Carissic acid monoacetate C. carandas Leaf [25]
13 Carissol C. carandas Fruit [27]
14 13,27-Cyclosuran-3-one C. congesta Root [17]


















18 3b-Hydroxyolean-11-en-28,13b-olide C. macrocarpa Fruit [18]
19 Friedours-7-en-3-one C. congesta Root [17]
20 Arjunolic acid C. opaca Aerial [26]
21 Carandinol C. carandas Leaf [24]
22 Betulinic acid C. carandas Leaf [24]
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Table 2 continued
Nos. Compounds Plant sources Parts References
23 Evomonoside C. spinarum Root [28, 34]






























27 2a-Carissanol C. edulis Root [8, 10]
28 6a-Carissanol C. edulis Root [8, 10]
C. edulis Root [8]
29 (?)-6b-Carissanol C. edulis Root [8, 10]
30 (±)-Aristolone (sesquiterpene) C. opaca Root [13]
31 4-Epi-aubergenone C. edulis Root [10]














C. edulis Root [8]








C. opaca Root [6]
38 Zicrone C. opaca Root [13]


















42 Pinene C. edulis Root [4]
43 Myrcene C. edulis Root [4]
44 Limonene C. edulis Root [4]
C. opaca Root [6]
45 Sabanene C. edulis Root [4]






47 Menthol C. carandas Flower [7]















Nos. Compounds Plant sources Parts References






51 Citronellal C. carandas Flower [7]
52 Linalyl acetate C. grandiflora Flower [7]
53 (±)-Linalool C. carandas Flower [7]
54 Neryl acetate C. carandas Flower [7]
55 Geranyl acetate C. carandas Flower [7]
56 b-Ionone C. carandas Flower [7]
57 c-Terpenene C. grandiflora Flower [7]
58 Geraniol C. grandiflora Flower [7]
59 2-Isopropenyl-5-methyl-6-hepten-1-ol C. congesta Root [17]












61 Epicatechin C. carandas Fruit [32]















64 Kaempferol C. carandas Fruit [32]
65 Naringin C. spinarum Leaf [19]
66 3,5-Dihydroxy-30,40,7-trimethoxy-flavone 3-b-D-
glucoside
C. edulis Leaf [5]

















C. carandas Root [35]















71 4,40-Dimethylcarinol C. carandas Root [35]
72 1,2,4-Butanetriol, 2,3-bis[[4-(acetyloxy)-3-
methoxyphenyl] methyl]-,1,4-diacetate
C. carandas Root [35]
73 Lariciresinol C. edulis Root [9]
74 90-O-methyl-(8R,80R,90S)-carrisanol C. edulis Root [9]
75 90-O-methyl-(8R,80R,90R)-carrisanol C. edulis Root [9]
76 3-(4-Methoxyphenyl)-2,6-dimethyl-benzofuran C. opaca Root [13]
77 (-)-Olivil C. edulis Root [9, 21]






79 8-Hydroxypinoresinol C. spinarum Stem [34]
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Table 2 continued
Nos. Compounds Plant sources Parts References
























83 Campesterol C. spinarum Root [37]
84 Cholest-5-en-3b-ol C. carandas Root [38]
85 Stigmasterol glucoside C. edulis Leaf [5]
86 Stigmasterol C. spinarum Root [37]
87 3b,5a-Stigma-7,25-dien-3-ol C. congesta Root [17]
88 3b,5a-Stigma-7,16-dien-3-ol C. congesta Root [17]
89 Chrondrillasterol C. congesta Root [17]
90 Piceatannol C. carandas Fruit [32]
91 Resveratrol C. carandas Fruit [32]
92 Syringic acid C. carandas Fruit [32]
93 Vanillic acid C. carandas Fruit [32]






95 3,40-Dihydroxypropiophenone C. edulis Root [9]
96 Coniferaldehyde C. spinarum Stem [21, 34]
97 p-Coumaric acid C. carandas Fruit [32]
98 Caffeic acid methyl ester C. edulis Leaf [5]






100 Ellagic acid C. carandas Fruit [32]






102 Chlorogenic acid C. carandas Fruit [32]
103 Chlorogenic acid-1-methylester-1-ethylether C. edulis Leaf [5]









105 Isofraxidin C. edulis Root [9]
106 Eicosanoic acid C. carandas Seed [40]
107 Hexadecanoic acid C. carandas Seed [40]
108 Octadecanoic acid C. carandas Seed [40]
109 9Z,12Z-octadecadienoic acid C. carandas Seed [40]
110 9Z-octadecenoic acid C. carandas Seed [40]
111 30-(400-Methoxyphenyl)-30-oxo-propionyl
hexadecanoate
C. spinarum Stem [21]
112 Hexadecanoic acid 2-hydroxyl-1-
(hydroxymethyl) ethyl ether
C. congesta Root [17]
113 Butyl-9,12-octadecadienoate C. congesta Root [17]
114 2-Benzenedicarboxylic acid, mono(2-
ethylhexyl) ester
C. opaca Root [6]
115 L-Ascorbic acid C. carandas Fruit [32]
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to lower blood pressure has been previously reported to be
attributed to the presence of the odoroside glucosides,
odorosides H (24) and F [10].
In an effort by Wangteeraprasert R. et al. to find new
antiherpetic agents from the stems of C. spinarum [34], the






1 R1 = R3 = H, R2= CH3
2 R1 = H, R2= COOH, R3 = OH
3 R1 = R3 = H, R2= CH2OH
4 R1 = A, R2= CH3, R3 = H






15 R1 = COOH, R2 = R3 = H
16 R1 = CH3, R2 = R3 = H
17 R1 = COOCH3, R2 = R3 = H





6 R1 = COOH, R2 = H
7 R1 = CH3, R2 = OH
8 R1 = COOCH3, R2 = H














10 R1 = H, R2 = H
11 R1 = CH3, R2 = H
12 R1 = H, R2 = Ac


























Fig. 1 Triterpenes 1–22 from Carissa
Table 2 continued
Nos. Compounds Plant sources Parts References
116 Dihydrojasmone C. carandas Flower [7]
117 4-Amino-1-(4-amino-2-oxo-1(2H)-pyrimidinyl)-
1,4-dideoxy-b-D-glucopyranuronic acid
C. carandas Root [30]
118 6-Decaprenylphenol C. carandas Root [30]
119 9-Octadecene C. congesta Root [17]
120 Tritriacontane C. bispinosa Leaf [20]
121 Vitamin E C. opaca Root [6]
122 Naphthalenone C. opaca Root [4]
123 Pinitol C. edulis Leaf [5]
J. S. Kaunda, Y.-J. Zhang
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only antiherpetic principle, showing moderate activity
against herpes simplex virus (HSV) types I and II in the
inactivation method [34].
So far, only two cardiac glycosides, evomonoside (23)
and odoroside H (24) have previously been identified from
the roots of C. spinarum [28, 34]. Odoroside H (24) was
also isolated from the roots of C. lanceolata [29]. Mohr K.
et al. reported that the roots of C. ovata also contain a little
odoroside H [29] (Fig. 2).
3.3 Sesquiterpenes
Sesquiterpenes of Carissa have been shown to possess
antimicrobial, antimalarial, anticancer and anti-inflam-
matory effects [10]. Sixteen compounds 25–40 have been
isolated from seven Carissa species (Table 2; Fig. 3).
They have been identified from the roots of C. edulis
[7, 8], C. congesta [11], C. opaca [13], C. lanceolata
[1, 12, 29], and the flowers of C. grandiflora and C.
carandas [6]. They comprise 10 sesquiterpenes cyclized
into two adjoining cyclohexane ring configuration
known as eudesmane type (26–34), an aristolane
sesquiterpenoid (35) and a sesquiterpene cyclized to one
10-carbon ring known as germacrane derivative (36),
isolated majorly from the methanolic extract of the roots
of C. edulis [8, 10]. Lindsay et al. carried out an inves-
tigation on the dichloromethane extract of the wood of
C. lanceolata [1] and isolated carindone (25), carissone
(26) and dehydrocarissone (32). It is noted that 25 is a
sesquiterpene dimer with two eudesmane units con-
nected by an additional ketone group. Further pharma-
cological test against Staphylococcus aureus,
Escherichia coli and Pseudomonas aeruginosa indicated











23 R1 = H
24 R1 = CH3




26 R1 = R2 = H
27 R1 = OH, R2 = H
28 R1 = H, R2 = α-OH

































Fig. 3 Sesquiterpenes 25–40 from Carissa
The Genus Carissa
123
carindone (25) and dehydrocarissone (32) having a
minimum inhibitory concentration (MIC) less than
0.5 mg/mL against S. aureus and E. coli [1].
Galipali S. et al. investigated the anti-inflammatory
potential of root methanol extracts of C. carandas using
bioassay guided fractionation of extract based on inhibi-
tory potential towards proinflammatory mediators (TNF-
a, IL-1b and NO). They found out that carissone (26)
exhibited potential anti-inflammatory agents as well as
significant inhibition of NO production comparable to
specific NO inhibitor without affecting the cell viability
[56].
3.4 Monoterpenes
Eighteen compounds 41–59 (Fig. 4) have been isolated
from the root oil of C. edulis [4] and C. opaca [6]. They
also constitute the volatile oil of flowers of C. carandas and
C. grandiflora [7].
3.5 Flavonoids
This class of polyphenolic compounds occurs in any of
the chemical structures such as flavones, flavonols, fla-
vanons and flavanols. Compounds 60–66 (Fig. 5) have
42 43 44 45 46






















61 R = H
































60 R1 = OH, R2 = Rha(1 6)-Glc-
63 R1 = OH, R2 = H
64 R1 = R2 = H
R1
Glc
Fig. 5 Flavonoids 60–66 from Carissa
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been isolated from Carissa species. Patil B. et al. isolated
rutin (60), epicatechin (61), epicatechin gallate (62) and
quercetin (63) from the berries of C. carandas [32]. Rutin
(60) and kaempferol (64) isolated from the aerial parts of
C. edulis displayed anti-inflammatory, arterial blood
pressure and anti diuretic activities [5]. Sahreen S. et al.
carried out an investigation on the fruits of C. opaca and
reported that polyphenols and flavonoids had potent
antioxidant activities in scavenging 2,2-diphenyl-1-
picrylhydrazyl (DPPH), superoxides, hydroxyl, hydrogen
peroxide, and ABTS radicals, and had strong iron
chelating activity [81]. The ethyl acetate fraction showed
the highest inhibition of b-carotene/linoleic acid peroxi-
dation and phosphomolybdate assay. There were high
correlations between half maximal effective concentration
(EC50) values of DPPH, superoxide, hydroxyl, hydrogen
peroxide, ABTS radical, total phenolics and flavonoids,
but no significant correlation for iron chelators, b-car-
otene, and phosphomolybdate assay. Thus, the chloroform
and aqueous extracts had strong antioxidant activities
which correlated with high levels of polyphenols and
flavonoids. These fractions may become sources of
antioxidants and/or functional food ingredients.
From the literature, rutin (60) and quercetin (63) are
the most predominant flavonoids in Carissa
[5, 6, 32, 33].
3.6 Lignans
Lignans is a class of natural products occupying quite a
large portion in plants. They have been identified in about
70 families, many of which have been applied in traditional
medicine. Due to their various biological effects including
antimitotic, antiviral, cathartic, allergenic and antitumor
activities, lignans have gained increasing attention and
research interests [10]. Moreover, they are reviewed to
possess antioxidant activity hence present exciting oppor-
tunities for their development as a new therapeutic base for
the treatment of polygenic disorders involving oxidative
stress [21].
Thirteen lignans 67–80 (Fig. 6) were isolated from
Carissa species, mostly from the roots and stems as com-
pared to the other parts of the plant. Carissanol (68), carinol
(70), (?)-nortrachelogenin (78) and pinoresinol (80) were
the most lignans characterized from the roots of C. edulis
[5, 9, 21] and C. carandas [35], and stems of C. lanceolata
[19] and C. spinarum [21, 34]. It is noted that carissanol
(68) possessed a hemiacetal group in molecule. All three
lignans carissanol (68), carinol (70) and nortrachelogenin
(79) have shown to exhibit cytotoxicity against breast
(MCF7) and lung (A549) cancer cells as well as moderate
anti-DPPH free radical activity [21, 34], while (?)-nor-





69 R1 = CH3, R2 = Ac
70 R1 = R2 = H
71 R1 = CH3, R2 = H















79 R = OH






74 R = αOCH3































Fig. 6 Lignans 67–80 from Carissa
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a dose of 14.50 lg/mL [5, 9]. In addition, carinol (70)
showed considerable antimicrobial activity against four
bacteria, P. aeruginosa, E. coli, Staphylococcus aureus and
Bacillus subtilis, with a MIC of\1.25 mg/mL, by a micro
broth dilution technique [36].
3.7 Sterols
Sterols 81–89 of Carissa (Fig. 7) have indicated possession
of hepatoprotective, anti-inflammatory, anti-HIV and anti-
hyperlipidemic activities [10]. They have been isolated from
the roots of C. congesta [11, 17], C. spinarum [37], and C.
carandas [15, 31, 38]. b-Sitosterol (84) is the most common
sterol in Carissa and it is present in the leaves of C. edulis [5],
roots of C. opaca [6] and C. carandas [15, 31, 38].
Galipali S. et al. investigated the anti-inflammatory
potential of root methanol extracts of C. carandas using
bioassay guided fractionation of extract based on inhibitory
potential towards proinflammatory mediators (TNF-a, IL-
1b and NO). They found out that stigmasterol (86) exhib-
ited potential anti-inflammatory agents [56].
3.8 Simple Phenolic Compounds
Phenolic compounds form the largest group of secondary
metabolites produced by plants, mainly, in response to
biotic or abiotic stresses such as infections, wounding, UV
irradiation, exposure to ozone, pollutants and other hostile
environmental conditions. They are mostly hydroxyben-
zoic and hydroxycinnamic acid derivatives. There has been
increased interest towards natural and synthetic phenyl
propanoids for medicinal use as antioxidant, UV screens,
anticancer, antivirus, anti-inflammatory, wound healing
and antibacterial activities [10, 55, 56].
Isolation of 16 phenolic compounds, 90–105 (Fig. 8) has
been achieved from the fruits, roots, and stems of C.
carandas [14, 32], C. edulis [5, 9], C. lanceolata [1], C.
opaca [6, 13], and C. spinarum [31]. Coniferaldehyde (96)
isolated from the stems of C. spinarum [31], was reported
to inhibit LPS-induced apoptosis through the PKC a/b II/
Nrf-2/HO-1 dependent pathway in RAW264.7 macrophage
cells [82]. p-Coumaric acid (97), isolated from the fruits of
C. carandas [32], and their derivatives had shown to exert
anti-coagulant, anti-tumor, anti-viral, anti-inflammatory
and antioxidant effects, as well as anti-microbial and
enzyme inhibition properties [10]. Chlorogenic acid (102),
isolated from the fruits of C. carandas [32], and their
derivatives, possess antioxidants that might contribute to
the prevention of type II diabetes mellitus, cardiovascular
disease and certain aging related diseases [10].
Galipali S. et al. investigated the anti-inflammatory potential
of root methanol extracts ofC. carandas using bioassay guided
fractionation of extract based on inhibitory potential towards
proinflammatory mediators (TNF-a, IL-1b and NO). They
found out that the coumarin, scopoletin (104) exhibited sig-
nificant inhibition ofNOproduction comparable to specificNO
inhibitor without affecting the cell viability [56].
3.9 Fatty Acids and Esters
Nine fatty acids and esters (106–114) have been reported
from the genus Carissa (Fig. 9). Five saturated (106–108)
and unsaturated (109–110) fatty acids were isolated from
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30-(400-methoxyphenyl)-30-oxo-propionyl hexadecanoate
(111) from C. spinarum [21], hexadecanoic acid 2-hy-
droxyl-1-(hydroxymethyl) ethyl ether (112) and butyl-9,12-
octadecadienoate (113) from C. congesta [17], and 2-ben-
zenedicarboxylic acid mono (2-ethylhexyl) ester (114)
from C. opaca [6], were also obtained.
3.10 Others Compounds
In addition to terpenoids, flavonoids, sterols, lignans,
simple phenolics, fatty acids and esters, nine other types of
compounds (115–123) have been isolated from Carissa
species (Fig. 10). They comprise L-ascorbic acid (115),
dihydrojasmone (116), 4-amino-1-(4-amino-2-oxo-1(2H)-
pyrimidinyl)-1,4-dideoxy-b-D-glucopyranuronic acid (117)
and 6-decaprenylphenol (118) from the flowers and roots of
C. carandas [7, 32], an alkene (119) from the roots of C.
congesta [17], an alkane (120) from the leaves of C. bis-
pinosa [20], a naphthalenone (121) and vitamin E (122)
from the roots of C. opaca [4, 6], and a cyclohexanehexol,
pinitol (123) from the leaves of C. edulis [5].
4 Pharmacological Studies
Researchers have investigated pharmacological activities
of Carissa species based on their claimed ethnomedicinal
and anecdotal uses, including anti-plasmodial, diuretic
effect, anticonvulsant, antibacterial, antioxidants and anti-
tumor, antiviral, analgesic, anti-inflammatory, antipyretic,
vasorelaxant, antihypertensive, cardioprotective and hep-









90 R = OH
















92 R1 = OH, R2 = OCH3
93 R1 = OH, R2 = H





102 R = H
103 R = CH3
R
R2 96 R1 = H, R2 = OCH3
97 R1 = OH, R2 = H
98 R1 = OCH3, R2 = OH





104 R = H













109 R = H










106 n = 15, R = H
107 n = 11, R = H
108 n = 13, R = H
111 n = 11, R = A
112 n = 11, R = B
A B C




Traditionally, the Meru and Kilifi communities of Kenya
use the decoction of the root bark of C. edulis for treatment
of malaria and other ailments [41]. In an investigation to
determine anti-plasmodial activity of C. edulis, Plasmod-
ium falciparum in vitro drug sensitive study was conducted
in order to evaluate the correlation between the ethno
medicinal use and bioactivity of the plant’s methanolic root
bark extract. The extract showed anti-plasmodial activity
against the chloroquin sensitive (D6) strain of P. falci-
parum parasite with minimum inhibition concentration for
inhibiting 50% of the pathogen (IC50) value of 1.95 lg/mL.
From this experiment, a lignan compound nortrachelo-
genin(78) was isolated and it showed antiplasmodium
activity of 14.50 lg/mL [5].
4.2 Diuretic Effect
It is reported that the diuretic activities of different extracts
of C. edulis were investigated orally at a dose range of
50–1000 mg/kg in rats using hydrochlorothiazide as a
standard drug. The root bark soxhlet extract produced a
significant increase (P\ 0.05) in urine output at a dose of
1000 mg/kg. The root wood maceration and root wood
soxhlet extracts produced a significant increase in urine
output at a dose of 50 mg/kg, with a P value of\0.05.
Urinary electrolyte excretion was also affected by the
extracts. The root bark soxhlet extract increased urinary
excretion of sodium, potassium and chloride ions while the
root wood maceration extract increased excretion of
sodium and potassium and the root wood soxhlet extract
increased excretion of potassium ion. These findings sup-
port the traditional use of C. edulis as a diuretic agent [42].
4.3 Anticonvulsant Activity
In a study to investigate anticonvulsant activity of root bark
extract of C. edulis, the median lethal dose (LD(50)) of its
extract was determined using Lork’s method and the anti-
convulsant activity of the extract was assessed in
pentylenetetrazole—induced convulsion in mice and
maximal electroshock test (MEST) in chicks, with benzo-
diazepine and phenytoin as standard drugs, respectively.
Parallel studies were also conducted using both flumazenil,
a neurotransmitter gamma-aminobutyric acid (GABA)
(A)—benzodiazepine receptor complex site antagonist and
naloxone a non-specific opioid receptor antagonist. The
LD(50) of C. edulis was 282.8 mg/kg and over 5000 mg/kg
following intraperitoneal and oral administration, respec-
tively. C. edulis extract produced 40 and 20% protection
against convulsion at 5 and 20 mg/kg, respectively, com-
pared with 100% protection with benzodiazepine. Essen-
tially, the mean onset and percentage protection against
convulsion in C. edulis extract-treated mice were reduced
by flumazenil and naloxone. C. edulis extract exhibited
dose-dependent inhibition of the convulsion induced by
MEST with 20 mg/kg providing 90% protection while
phenytoin (20 mg/kg) produced 100% protection. The
results showed that the root extract of C. edulis possesses
biologically active constituent(s) that have anticonvulsant
activity which supports the ethnomedicinal claims of the
use of the plant in the management of epilepsy [43].
4.4 Antibacterial Activity
While investigating antibacterial activity of the extracts of
leaves, stems and roots of C. carandas using disc diffusion
assay, MIC, minimum bactericidal concentration, total
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Streptococcus aureus was found to be the most susceptible
organism followed by B. subtilis and E. coli. Flavonoid of
roots showed the best activity against B. subtilis
(IZ = 15 mm, MIC = 0.312 mg/mL, MBC = 0.156 mg/
mL, TA = 3.20 mL/g). Results revealed that extracts of C.
carandas have good antimicrobial potential and may be
exploited for antimicrobial drugs [44]. In another study, the
dichloromethane and toluene extract of the leaves of C.
carandas showed better results against Staphylococcus
aureus and Klebsiella pneumonia. The fruit extract of C.
carandas in dichloromethane exhibited high antibacterial
activity against E. coli. The fruit extract in ethyl acetate
showed the best result against all the strains of bacteria
[45]. In another investigation carried out on the root extract
of C. opaca, the sample exhibited considerable antimicro-
bial activities against B. subtilis, E. coli, P. aeruginosa,
Candida albicans and Aspergillus niger with zones of
inhibition ranging from 10 to 13 mm as compared to the
standard drug amoxicillin with zones of inhibition
13–17 mm under similar conditions. The roots of C. opaca
can provide new leads for future antimicrobial drugs [13].
Further antibacterial studies on naringin(65) and ursolic(6)
acid isolated from the leaves of C. spinarum had similar
antibacterial activities and they completely inhibited the
pathogenic Gram negative bacteria which causes diarrhea
and dysentery [19].
4.5 Antioxidants and Anti-tumor Activity
While carrying out cytotoxicity investigation on C. caran-
das extracts against cancer cell lines, the compound
carandinol (21) from the leaves of C. carandas [24]
exhibited significant in vitro cytotoxicity to every cell line
tested (HeLa, PC-3 and 3T3) and was relatively more toxic
to human cervical cancer (HeLa) cell line [24]. Lignans
carissanol (68), carinol (70) and nortrachelogenin (78),
from the stems of C. spinarum [34] have been shown to
exhibit cytotoxicity against breast (MCF7) and lung (A549)
cancer cells. Moreover, moderate anti-DPPH free radical
activity has been observed for all the lignans [21, 46]. In a
different study, C. spinarum aqueous extract and its n-bu-
tanol fraction exhibited potential cytotoxic effect on a wide
range of human cancer cell lines, with apoptotic activity in
human leukaemia HL-60 cells through the mitochondrial
dependent pathway in HL-60 cells [47]. In another inves-
tigation to determine the antioxidant and DNA damage
inhibition potential of leaf methanolic extract of C. caran-
das, the extract had significant (P\ 0.05), dose-dependent
DPPH radical scavenging activity (median inhibitory con-
centration 73.1 lg/mL), total antioxidant activity, H2O2
scavenging activity (median inhibitory concentration
84.03 lg/mL) and reducing power activity. It was also
found out that the extract completely protected pBR 322
plasmid DNA from free radical-mediated oxidative stress in
a DNA damage inhibition assay. The antioxidant and DNA
damage inhibition properties of C. carandas can be attrib-
uted to a high content of phenolic compounds (84.0 mg
gallic acid equivalents/g dry weight of extract). The high
antioxidant and DNA damage inhibiting potential of C.
carandas could be used to develop antioxidant compounds
for therapeutic applications [48]. Further cytotoxicity
investigations have been performed on C. opaca extracts. In
one of such studies, C. opaca extracts and fractions were
tested against MCF7 breast cancer cell line using 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) assay, a concentration dependent inhibition of
78.5% activity was observed for the crude extracts against
cancer cells at a concentration of 500 lg/mL. Fractions
were tested at a concentration of 200 lg/mL and were more
active than crude extracts. Chloroform fraction showed
maximum inhibition of 99% followed by ethyl acetate and
methanol fraction exhibiting 96 and 94% inhibition,
respectively [49].
4.6 Antiviral Activity
In a certain investigation, an aqueous total extract prepa-
ration of the roots of C. edulis exhibited remarkable anti-
HSVs activity in vitro and in vivo for both wild type and
resistant strains of HSV. The extract significantly inhibited
formation of plaques in Vero E6 cells infected with 100
plaque forming units of wild type strains of HSV (7401 H
HSV-1 and Ito -1262 HSV-2) or resistant strains of HSV
(TK (-) 7401H HSV-1 and AP (r) 7401H HSV-1) by 100%
at 50 mg/mL in vitro with minimal cell cytotoxicity
(CC50 = 480 mg/mL). When the extract was examined for
in vivo efficacy in a murine model using Balb/C mice
infected with wild type or resistant strains of HSV, the
extract, at an oral dose of 250 mg/kg, significantly delayed
the onset of HSV infections by over 50%. It also increased
the mean survival time of treated infected mice by between
28 and 35% relative to the infected untreated mice
(P\ 0.05 vs. control by Student’s t-test). The mortality
rate for mice treated with extract was also significantly
reduced by between 70 and 90% as compared with the
infected untreated mice that exhibited 100% mortality. No
acute toxicity was observed in mice at the oral therapeutic
dose of 250 mg/kg. These results suggest that the root
aqueous extract of C. edulis contain potent anti-viral agents
against HSVs that can be exploited for development of an
alternative remedy for HSV infections [50, 51]. A separate
investigation on the hexane extract of C. edulis displayed
moderate activity against feline herpes virus 1 with
EC50\70 mg/mL and SI value \2. On the other hand,
excellent activity was exhibited with the hexane extracts of




A study conducted to explore the antiemetic activity of the
fruit ethanol extract of C. carandas using chick emetic
model showed a decrease in retches induced by copper
sulfate pentahydrate given orally at 50 mg/kg body weight
[53].
4.8 Anti-hyperlipidemic Activity
The lipid lowering activity of aqueous: ethanol (1:1)
extract of C. carandas in egg yolk induced hyperlipidemic
rats showed a highly significant increase in the weight of
high cholesterol diet rats. The extract caused a significant
reduction in body weight, cholesterol, triglycerides, HDL
and LDL in hyperlipidemic rats. Histopathological changes
induced by high cholesterol diet were also significantly
reduced by the extract. The activity of the extract of C.
carandas at a dose of 1000 mg/kg was comparable to that
of atorvastatin at a dose of 0.2 mg/kg [54].
4.9 Analgesic, Anti-inflammatory and Antipyretic
Activities
Analgesic activity of C. carandas was studied in mice
using hot plate and acetic acid induced writhing methods,
while carrageenan induced paw edema was used to access
anti-inflammatory activity. The antipyretic activity was
evaluated by Brewer’s yeast induced pyrexia in rats.
Ethanol and aqueous extracts from roots of C. carandas
exhibited significant (P\ 0.01) analgesic, anti-inflamma-
tory and antipyretic activities at doses of 100 and 200 mg/
kg body weight. In analgesic activity, the highest per-
centage of inhibition of abdominal constriction (72.67%)
was observed for ethanol extracts of C. carandas at a dose
of 100 mg/kg body weight. The ethanol and aqueous
extracts from C. carandas were found to reduce signifi-
cantly the formation of edema induced by carrageenan after
2 h. Both the extracts of C. carandas showed significant
antipyretic activities on yeast induced hyperpyrexia in rats
after 2 h. The results of this study indicated that the ethanol
and aqueous extracts from the roots of C. carandas possess
significant analgesic, anti-inflammatory and antipyretic
activities in rodent models [55]. In a separate study to
investigate the anti-inflammatory potential of root metha-
nol extracts of C. carandas involving bioassay guided
fractionation of extract based on inhibitory potential
towards proinflammatory mediators (TNF-a, IL-1b and
NO), it was found out that lupeol (1), oleanolic acid (15),
carissone (26), stigmasterol (86), and scopoletin (104)
possess potential anti-inflammatory agents. Carissone (26)
and scopoletin (104) exhibited significant inhibition of NO
production comparable to specific NO inhibitor without
affecting the cell viability [56]. C. spinarum has been used
traditionally for the treatment of inflammation-related
disorders such as rheumatic pain and to relieve fever.
Based on this information, ethanolic extract of the roots of
C. spinarum was evaluated for its antipyretic activity.
Wistar albino rats were induced with Brewer’s yeast
(2 mL/kg) for pyrexia and antipyretic activity was assessed
with 100, 200 and 400 mg/kg ethanolic extract. The
ethanolic extract significantly (P\ 0.05) reduced the ele-
vated body temperature in a dose dependent manner [57].
4.10 Vasorelaxant and Antihypertensive Activities
In an effort to investigate vasorelaxant activity of the
leaves of C. spinarum extracts as a possible source of
compounds with antihypertensive effects, an experiment
was carried out using an ex vivo method. All tested extracts
caused concentration-dependant relaxation in pre-con-
tracted aortic rings. The dichloromethane soluble extracts
from the leaves of C. spinarum was the most active
(EC50 = 0.17 ± 0.01 mg/mL, Emax = 85.72%). The abil-
ity of the extracts in this study to cause relaxation of the
aortic rings pre-contracted with phenylephrine could
rationally explain the use of C. spinarum to treat hyper-
tension by Malagasy traditional healers in Madagascar
[58].
4.11 Cardioprotective
The protective effects of various fractions of leaf extract of
C. opaca against carbon tetrachloride (CCl4) administra-
tion was reviewed by rat cardiac functions alterations.
Chronic toxicity caused by 8 week treatment of CCl4 to the
rats significantly changed the cardiac function test,
decreased the activities of antioxidant enzymes and glu-
tathione contents whereas significant increase was found in
lipid peroxidation. Administration of various fractions of
the extract with CCl4 showed protective ability against
CCl4 intoxication by restoring the cardiac functions alter-
ations, activities of antioxidant enzymes and lipid peroxi-
dation in rat. CCl4 induction in rats also caused DNA
fragmentation and histopathological abnormalities which
were restored by administration of various fraction of C.
opaca leaves extract. Results revealed that various fraction
of C. opaca are possess in cardio-protective agents [59].
4.12 Hepatoprotective Activity
Ethyl acetate fraction of the ethanol extract from roots of
C. carandas was studied against CCl4-, paracetamol-, and
ethanol-induced hepatotoxicity in rats. Significant hepato-
protective effects were obtained against liver damage
induced by all the three toxins, as indicated by changed
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biochemical parameters like serum transaminases, alkaline
phosphate, total bilirubin, total protein, and total choles-
terol. The ethyl acetate fraction prevented toxin-induced
oxidative stress by significantly maintaining the levels of
reduced glutathione and malondialdehyde, and a normal
functioning of the liver, compared to toxin controls [38]. C.
carandas root extract is used by tribal healers of Western
Ghat region of Karnataka as hepatoprotective and antihy-
perglycemic [60]. A study was conducted to evaluate the
hepatoprotective effects of the ethanol and aqueous
extracts of roots of C. carandas against ethanol induced
hepatotoxicity in rats. Their liver function test, serum lipid
profile, levels of lipid peroxidation and the activity of liver
antioxidant enzyme glutathione were established at a dose
level of 100 and 200 mg/kg. The effect produced signifi-
cant hepatoprotection by decreasing serum transaminase
bilirubin and lipid peroxidation, while it significantly
increased the levels of liver glutathione and serum protein
[61]. In another similar investigation, oral pre-treatment
with ethanolic extract of the roots of C. carandas showed
significant hepatoprotective activity against CCl4 and
paracetamol induced hepatotoxicity by decreasing the
activities of serum marker enzymes, bilirubin and lipid
peroxidation, and significant increase in the levels of uric
acid, glutathione, super oxide dismutase, catalase and
protein in a dose dependent manner, which was confirmed
by the decrease in the total weight of the liver [62].
4.13 Other Effects
Oral administration of the ethanolic extracts of the leaves
of C. edulis on blood glucose levels both in normal and
streptozotocin (STZ) diabetic rats significantly reduced the
blood glucose level in STZ diabetic rats during the first 3 h
of treatment [63]. The roots of C. carandas are used in the
treatment of helminthiasis [64] Tannins from the leaves of
C. spinarum possess antihelminthic properties [65].
A study conducted to investigate inhibitory activities of
the methanolic extract, ethyl acetate and chloroform,
aqueous and hexane fractions of C. opaca roots against
xanthine oxidase (XO) and alpha-amylase enzymes showed
significant results. Methanolic extract displayed significant
activity against both the enzymes with IC50 of 156.0 and
5.6 mg/mL for XO and alpha-amylase, respectively. Ethyl
acetate fraction showed highest activity against both the
enzymes with IC50 of 129 and 4.9 mg/mL for XO and
alpha-amylase, respectively. Chloroform fraction had IC50
of 154.2 and 5.5 mg/mL for XO and alpha-amylase,
respectively. Aqueous fraction exhibited significant effi-
cacy against alpha-amylase (IC50 5.0 mg/mL). Hexane
fraction showed good activity against alpha-amylase in a
dose-dependent manner but exhibited opposite trend
against XO [6].
Crude extract of C. carandas possesses laxative and
antidiarrheal properties mediated through combinations of
gut stimulant and inhibitory activities. The gut stimulant
potential of C. carandas was found mediated through
combination of muscarinic and histaminergic receptors
activation, while its gut inhibitory activity was observed
mediated through antagonistic pathway. This study pro-
vides a rationale for the medicinal use of C. carandas in
constipation and diarrhea [67]. The roots of C. carandas
and C. spinarum are used as a purgative and as an antidote
for snakebite, and the leaves for remittent fever [68].
In vitro inhibitory activity of leaf extracts of C. spinarum in
non-polar and polar solvents was determined against
Bungarus caeruleus and Vipera russelli toxic snake venom
enzymes. Methanol extracts (100 lg/mL) inhibited
acetylcholinesterase, phospholipase A2, hyaluronidase,
phosphomonoesterase, phosphodiesterase, 50-nucleotidase
enzymes of B. caeruleus and V. russelli venoms [69].
Ethanol extract from the roots of C. spinarum has
exhibited ability to lower blood pressure in cats [77]. The
in vivo wound healing activity of 1 and 2.5% (w/w) C.
spinarum extract was assessed on a burn wound model in
mice by the rate of wound contraction, period of epithe-
lization and hydroxyproline content and the results showed
that C. spinarum root extract has significant wound healing
activity as evident from the rate of wound contraction and
epithelisation [77].
In the management of chronic joint pains in Machakos
County of Kenya, the leaves, stems and roots of C. spi-
narum are boiled in water and concoction drunk with soup,
one glass three times daily, for 14 days or until a patient
recovers [79].
Sahreen S. et al. carried out an investigation on the fruits
of C. opaca and reported that polyphenols and flavonoids
had potent antioxidant activities in scavenging DPPH,
superoxides, hydroxyl, hydrogen peroxide, and ABTS
radicals, and had strong iron chelating activity [81].
5 Conclusion and Future Prospects
From this review, it can be deduced that the major com-
pounds of Carissa are terpenes, lignans and simple phe-
nolic compounds. Amongst terpenes and lignans,
compounds such as carandinol (21) and nortrachelogenin
(78) have exhibited anti-tumor activity. The review high-
lights that compounds from fruits, leaves and roots of
Carissa not only contain biological properties but have also
exhibited significant biological activities such as antitumor,
antibacterial, antiplasmodial, antiviral, anti-hyperlipi-
demic, amongst others. It would therefore be important to
extensively investigate their phytochemicals and pharma-
cologically determine their activities for future drug
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discovery and development. Carissa seems to possess great
potential, yet majority of its species’ chemical constituents
remain unknown. It would be very necessary for the
pharmacology community to explore and investigate more
of its species in order to determine their chemical con-
stituents and report their potential.
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